Regutatory T-cells in type 1 diabetes

被引:10
作者
Juedes, AE [1 ]
von Herrath, MG [1 ]
机构
[1] La Jolla Inst Allergy & Immunol, Div Dev Immunol, San Diego, CA USA
关键词
autoimmunity; cytokines; regulation; therapy; T-cells;
D O I
10.1002/dmrr.508
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 1 diabetes is a T-cell-mediated autoimmune disease, resulting in destruction of the insulin-producing beta cells in the pancreas. Disease progression is thought to involve the action of T-cells particularly those understanding the producing Th1-type cytokines. Given the complexity in precise etiology of autoimmune diseases, the diversity of autoantigens, and the variability that exists between individual patients, it might be very difficult to eliminate autoaggressive T-cell responses without resorting to generalized means of immunosuppression. However, recent evidence shows that autoimmune processes are composed not only of autoaggressive T-cell responses but also of autoreactive regulatory components. Enhancing regulatory T-cell responses, therefore, has become an area of intense focus as a means of treating autoimmune diseases like type 1 diabetes. This review will concentrate on two different types of regulatory T-cells, the naturally occurring ('professional') CD4(+)CD25(+) T-cells and antigen-induced ('adaptive') CD4(+) Th2-like regulatory T-cells. Copyright (C) 2004 John Wiley Sons, Ltd.
引用
收藏
页码:446 / 451
页数:6
相关论文
共 50 条
  • [21] Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy - Moving Target for Industry?
    Salmikangas, Paula
    Kinsella, Niamh
    Chamberlain, Paul
    PHARMACEUTICAL RESEARCH, 2018, 35 (08)
  • [22] Type 1 diabetes immunotherapy using polyclonal regulatory T cells
    Bluestone, Jeffrey A.
    Buckner, Jane H.
    Fitch, Mark
    Gitelman, Stephen E.
    Gupta, Shipra
    Hellerstein, Marc K.
    Herold, Kevan C.
    Lares, Angela
    Lee, Michael R.
    Li, Kelvin
    Liu, Weihong
    Long, S. Alice
    Masiello, Lisa M.
    Vinh Nguyen
    Putnam, Amy L.
    Rieck, Mary
    Sayre, Peter H.
    Tang, Qizhi
    SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (315)
  • [23] Role of T-cells in the development of arthritis
    Gaston, JSH
    CLINICAL SCIENCE, 1998, 95 (01) : 19 - 31
  • [24] B cells and type 1 diabetes ... in mice and men
    Hinman, Rochelle M.
    Smith, Mia J.
    Cambier, John C.
    IMMUNOLOGY LETTERS, 2014, 160 (02) : 128 - 132
  • [25] CAR T-Cells
    Nair, Ranjit
    Westin, Jason
    IMMUNOTHERAPY, 3RD EDITION, 2020, 1244 : 215 - 233
  • [26] Self-Antigens Targeted by Regulatory T Cells in Type 1 Diabetes
    Mitchell, Angela M.
    Michels, Aaron W.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (06)
  • [27] The targeting of β-cells by T lymphocytes in human type 1 diabetes: clinical perspectives
    Luce, S.
    Briet, C.
    Becourt, C.
    Lemonnier, F.
    Boitard, C.
    DIABETES OBESITY & METABOLISM, 2013, 15 : 89 - 97
  • [28] Stroke and T-cells
    Thiruma V. Arumugam
    D. Neil Granger
    Mark P. Mattson
    NeuroMolecular Medicine, 2005, 7 : 229 - 242
  • [29] Stroke and T-cells
    Arumugam, TV
    Granger, DN
    Mattson, MP
    NEUROMOLECULAR MEDICINE, 2005, 7 (03) : 229 - 242
  • [30] Using the T Cell Receptor as a Biomarker in Type 1 Diabetes
    Nakayama, Maki
    Michels, Aaron W.
    FRONTIERS IN IMMUNOLOGY, 2021, 12